THE EXTENDED GESTATIONAL AGE MEDICAL ABORTION STUDY: THE EFFECTIVENESS OF MEDICAL ABORTION WITH 200 MG MIFEPRISTONE AND 400 MCG SUBLINGUAL MISOPROSTOL AT 57-63 DAYS VS. 64-70 DAYS GESTATION

被引:0
|
作者
Bracken, H. [1 ]
Attia, M. B. [1 ]
Chelli, H. [1 ]
Dabash, R. [1 ]
Hajri, S. [1 ]
Mundle, S. [1 ]
Platais, I [1 ]
Posohova, S. [1 ]
Raghavan, S. [1 ]
Shah, M. [1 ]
Swica, Y. [1 ]
Tsereteli, T. [1 ]
Tsertsvadze, G. [1 ]
Winikoff, B. [1 ]
Zerarmdini, D. [1 ]
机构
[1] Gynu Hlth Projects, New York, NY USA
关键词
D O I
10.1016/j.contraception.2011.05.127
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:303 / 303
页数:1
相关论文
共 24 条
  • [1] THE EXTENDED GESTATIONAL AGE MEDICAL ABORTION STUDY: THE EFFECTIVENESS OF MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL AT 57-63 DAYS VERSUS 64-70 DAYS GESTATION
    Swica, Y.
    Bracken, H.
    Shannon, C.
    Chong, E.
    Dzube, I
    Tsereteli, T.
    Maistruk, G.
    Winikoff, B.
    CONTRACEPTION, 2010, 82 (02) : 209 - 209
  • [2] Effectiveness and Safety of Medical Abortion with Mifepristone and Sublingual Misoprostol up to 63 Days of Gestation
    Saengbanyang, Prakasit
    Wongwananuruk, Thanyarat
    Panichyawat, Nalinee
    Powell, Natchara Sukapatrittikul
    Parkpinyo, Nichamon
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (10):
  • [3] Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation
    Hsia, Jennifer K.
    Lohr, Patricia A.
    Taylor, Jeanette
    Creinin, Mitchell D.
    CONTRACEPTION, 2019, 100 (03) : 178 - 181
  • [4] A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation
    Dzuba, Ilana G.
    Chong, Erica
    Hannum, Curtiss
    Lichtenberg, E. Steve
    Lugo Hernandez, Elba Margarita
    Nguyen Thi Nhu Ngoc
    Patel, Ashlesha
    Rzayeva, Gulnara
    Sanhueza Smith, Patricio
    Tsertsvadze, George
    Winikoff, Beverly
    CONTRACEPTION, 2020, 101 (05) : 302 - 308
  • [5] Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP a randomized controlled trial
    Raghavan, Sheila
    Comendant, Rodica
    Digol, Irena
    Ungureanu, Sergiu
    Dondiuc, Iurie
    Turcanu, Steliana
    Winikoff, Beverly
    CONTRACEPTION, 2010, 82 (06) : 513 - 519
  • [6] Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation
    Lokeland, Mette
    Iversen, Ole Erik
    Engeland, Anders
    Okland, Ingrid
    Bjorge, Line
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2014, 93 (07) : 647 - 653
  • [7] A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review
    Dzuba, Ilana G.
    Castillo, Philicia W.
    Bousieguez, Manuel
    Lugo Hernandez, Elba Margarita
    Castaneda Vivar, Jose Juan
    Sanhueza Smith, Patricio
    CONTRACEPTION, 2020, 102 (02) : 104 - 108
  • [8] Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days
    Fjerstad, Mary
    Sivin, Irving
    Lichtenberg, E. Steve
    Trussell, James
    Cleland, Kelly
    Cullins, Vanessa
    CONTRACEPTION, 2009, 80 (03) : 282 - 286
  • [9] Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore
    Tan, Yi-Ling
    Singh, Kuldip
    Tan, Kok Hian
    Gosavi, Arundhati
    Koh, Daniel
    Abbas, Dina
    Winikoff, Beverly
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 229 : 144 - 147
  • [10] Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol
    Raghavan, Sheila
    Comendant, Rodica
    Digol, Irena
    Ungureanu, Sergiu
    Friptu, Valentin
    Bracken, Hillary
    Winikoff, Beverly
    CONTRACEPTION, 2009, 79 (02) : 84 - 90